Search research articles
Contact Us
Filters
Showing results (11-20 of 256) with videos related to
Page
of 26
Sort By:
Seminars in Oncology
|
November 16, 2019
A systematic review on the emerging association between the occurrence of immune-related adverse events and clinical outcomes with checkpoint inhibitors in advanced cancer patients
Alessio Cortellini, Sebastiano Buti, Veronica Agostinelli, et al.
Journal of Thoracic Disease
|
November 19, 2020
A reflection on the actual place of osimertinib in the treatment algorithm of EGFR-positive non-small cell lung cancer patients
Alessio Cortellini, Corrado Ficorella, Roberto Crisci, et al.
Thoracic Cancer
|
December 12, 2018
Family history of cancer and DNA damage response genes: Two sides of the same coin?
Alessio Cortellini, Melissa Bersanelli, Corrado Ficorella, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 16, 2021
Response to letter entitled: Re: Predictive ability of a drug-based score in advanced non-small cell lung cancer patients receiving first-line immunotherapy
Alessio Cortellini, Melissa Bersanelli, David J Pinato, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
May 27, 2022
Antibiotic Exposure and Immune Checkpoint Inhibitors in Patients With NSCLC: The Backbone Matters
Alessio Cortellini, Francesco Facchinetti, Lisa Derosa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 17, 2020
Combined PD-1/VEGFR Blockade: A New Era of Treatment for Hepatocellular Cancer
David J Pinato, Petros Fessas, Alessio Cortellini, et al.
Journal of Hepatocellular Carcinoma
|
August 13, 2021
PD-1 Blockade for Hepatocellular Carcinoma: Current Research and Future Prospects
Antonio D'Alessio, Lorenza Rimassa, Alessio Cortellini, et al.
The Lancet. Gastroenterology & Hepatology
|
May 10, 2021
Therapeutic targeting of VEGFR2 in HBV-associated hepatocellular carcinoma
David J Pinato, Nicola Valeri, Ambreen Muhammed, et al.
Pharmaceutics
|
June 2, 2021
Targeting KRAS in Solid Tumors: Current Challenges and Future Opportunities of Novel KRAS Inhibitors
Alice Indini, Erika Rijavec, Michele Ghidini, et al.
Journal of Palliative Medicine
|
November 2, 2018
"Palliative" or "Supportive": Is It Just a Matter of Word?
Giampiero Porzio, Alessio Cortellini, Carla D'Orazio, et al.
Page
of 26
Search research articles
Search
Showing results (11-20 of 256) with videos related to
Sort By:
Page
of 26
Seminars in Oncology
|
November 16, 2019
A systematic review on the emerging association between the occurrence of immune-related adverse events and clinical outcomes with checkpoint inhibitors in advanced cancer patients
Alessio Cortellini, Sebastiano Buti, Veronica Agostinelli, et al.
Journal of Thoracic Disease
|
November 19, 2020
A reflection on the actual place of osimertinib in the treatment algorithm of EGFR-positive non-small cell lung cancer patients
Alessio Cortellini, Corrado Ficorella, Roberto Crisci, et al.
Thoracic Cancer
|
December 12, 2018
Family history of cancer and DNA damage response genes: Two sides of the same coin?
Alessio Cortellini, Melissa Bersanelli, Corrado Ficorella, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 16, 2021
Response to letter entitled: Re: Predictive ability of a drug-based score in advanced non-small cell lung cancer patients receiving first-line immunotherapy
Alessio Cortellini, Melissa Bersanelli, David J Pinato, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
May 27, 2022
Antibiotic Exposure and Immune Checkpoint Inhibitors in Patients With NSCLC: The Backbone Matters
Alessio Cortellini, Francesco Facchinetti, Lisa Derosa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 17, 2020
Combined PD-1/VEGFR Blockade: A New Era of Treatment for Hepatocellular Cancer
David J Pinato, Petros Fessas, Alessio Cortellini, et al.
Journal of Hepatocellular Carcinoma
|
August 13, 2021
PD-1 Blockade for Hepatocellular Carcinoma: Current Research and Future Prospects
Antonio D'Alessio, Lorenza Rimassa, Alessio Cortellini, et al.
The Lancet. Gastroenterology & Hepatology
|
May 10, 2021
Therapeutic targeting of VEGFR2 in HBV-associated hepatocellular carcinoma
David J Pinato, Nicola Valeri, Ambreen Muhammed, et al.
Pharmaceutics
|
June 2, 2021
Targeting KRAS in Solid Tumors: Current Challenges and Future Opportunities of Novel KRAS Inhibitors
Alice Indini, Erika Rijavec, Michele Ghidini, et al.
Journal of Palliative Medicine
|
November 2, 2018
"Palliative" or "Supportive": Is It Just a Matter of Word?
Giampiero Porzio, Alessio Cortellini, Carla D'Orazio, et al.
Page
of 26